| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |